Adam Taich's most recent trade in 10x Genomics Inc - Ordinary Shares - Class A was a trade of 4,044 Class A Common Stock done at an average price of $8.3 . Disclosure was reported to the exchange on May 22, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| 10x Genomics Inc - Ordinar... | Adam S. Taich | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 8.30 per share. | 22 May 2025 | 4,044 | 331,588 (1%) | 0% | 8.3 | 33,562 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | Adam S. Taich | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Oct 2024 | 201,704 | 201,704 (0%) | 0% | 0 | Class A Common Stock | |
| 10x Genomics Inc - Ordinar... | Adam S. Taich | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Oct 2024 | 133,928 | 335,632 (1%) | 0% | 0 | Class A Common Stock | |
| SomaLogic Inc - Ordinary S... | Adam Taich | Interim CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 855,000 | 855,000 | - | - | Employee Stock Option (Right to Buy) | |
| SomaLogic Inc - Ordinary S... | Adam Taich | Interim CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 592,000 | 592,000 | - | - | Restricted Stock Unit (RSU) |